La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Select Medical Holdings Gestione
Gestione criteri di controllo 1/4
Select Medical Holdings' Il CEO è David Chernow, nominato in Jan2014, e ha un mandato di 10.58 anni. la retribuzione annua totale è $ 10.71M, composta da 9.3% di stipendio e 90.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.78% delle azioni della società, per un valore di $ 33.36M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.4 anni e 10 anni.
Informazioni chiave
David Chernow
Amministratore delegato
US$10.7m
Compenso totale
| Percentuale dello stipendio del CEO | 9.3% |
| Mandato del CEO | 10.6yrs |
| Proprietà del CEO | 0.8% |
| Durata media del management | 1.4yrs |
| Durata media del Consiglio di amministrazione | 10yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125
Aug 05
Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher
Jul 19What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?
Jul 01Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?
Jun 13There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price
May 26Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
May 05Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely
Apr 19Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down
Apr 11Select Medical: Solid Growth Prospects And A Compelling Valuation
Mar 05Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely
Feb 18We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt
Jan 15Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes
Dec 31Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125
Nov 06Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors
Oct 25What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?
Oct 04Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?
Sep 16Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold
Aug 11Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125
Aug 07Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward
Jul 14At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?
Jun 29Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
May 27Select Medical: Revising To Hold As Business Economics Roll Lower
May 26Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital
Apr 05Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?
Mar 17Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line
Feb 23Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
Jan 31The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence
Dec 20Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?
Dec 01Select Medical declares $0.125 dividend
Nov 03These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively
Nov 01Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down
Sep 16Select Medical: Adding To Position For Further Upside Capture
Sep 14Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$259m |
| Mar 31 2024 | n/a | n/a | US$260m |
| Dec 31 2023 | US$11m | US$995k | US$235m |
| Sep 30 2023 | n/a | n/a | US$217m |
| Jun 30 2023 | n/a | n/a | US$196m |
| Mar 31 2023 | n/a | n/a | US$174m |
| Dec 31 2022 | US$9m | US$995k | US$153m |
| Sep 30 2022 | n/a | n/a | US$175m |
| Jun 30 2022 | n/a | n/a | US$223m |
| Mar 31 2022 | n/a | n/a | US$329m |
| Dec 31 2021 | US$12m | US$995k | US$389m |
| Sep 30 2021 | n/a | n/a | US$415m |
| Jun 30 2021 | n/a | n/a | US$415m |
| Mar 31 2021 | n/a | n/a | US$306m |
| Dec 31 2020 | US$8m | US$995k | US$250m |
| Sep 30 2020 | n/a | n/a | US$206m |
| Jun 30 2020 | n/a | n/a | US$162m |
| Mar 31 2020 | n/a | n/a | US$155m |
| Dec 31 2019 | US$8m | US$995k | US$143m |
| Sep 30 2019 | n/a | n/a | US$136m |
| Jun 30 2019 | n/a | n/a | US$138m |
| Mar 31 2019 | n/a | n/a | US$140m |
| Dec 31 2018 | US$8m | US$995k | US$133m |
| Sep 30 2018 | n/a | n/a | US$207m |
| Jun 30 2018 | n/a | n/a | US$193m |
| Mar 31 2018 | n/a | n/a | US$189m |
| Dec 31 2017 | US$7m | US$984k | US$171m |
Compensazione vs Mercato: La retribuzione totale di David ($USD 10.71M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 6.76M ).
Compensazione vs guadagni: La retribuzione di David è aumentata di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
David Chernow (67 yo)
10.6yrs
Mandato
US$10,706,265
Compensazione
Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.5yrs | US$10.77m | 6.89% $ 305.3m | |
| Chief Executive Officer | 10.6yrs | US$10.71m | 0.78% $ 34.4m | |
| Co-Founder & Chairman Emeritus | 27.5yrs | US$7.08m | 6.04% $ 268.0m | |
| Executive VP & CFO | less than a year | US$1.53m | 0.15% $ 6.9m | |
| Senior Executive VP | 27.5yrs | US$4.44m | 0.36% $ 15.9m | |
| Senior Executive Vice President of Strategic Finance & Operations | less than a year | US$6.47m | 1.01% $ 44.9m | |
| Co-President | less than a year | Nessun dato | 0.53% $ 23.7m | |
| Co-President | less than a year | Nessun dato | 0.28% $ 12.3m | |
| Senior VP | 1.4yrs | Nessun dato | 0.031% $ 1.4m | |
| Executive VP & Chief Information Officer | 3.6yrs | Nessun dato | 0.26% $ 11.5m | |
| Senior Vice President of Compliance & Audit | no data | Nessun dato | 0.029% $ 1.3m | |
| Senior VP & Chief Communications | less than a year | Nessun dato | Nessun dato |
1.4yrs
Durata media
55yo
Età media
Gestione esperta: Il team dirigenziale di SEM non è considerato esperto (durata media 1.4 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.5yrs | US$10.77m | 6.89% $ 305.3m | |
| Co-Founder & Chairman Emeritus | less than a year | US$7.08m | 6.04% $ 268.0m | |
| Independent Lead Director | 19.5yrs | US$384.40k | 0.84% $ 37.4m | |
| Independent Director | 20.5yrs | US$383.40k | 0.069% $ 3.0m | |
| Independent Director | 5.1yrs | US$405.80k | 0.051% $ 2.3m | |
| Independent Director | 14.3yrs | US$407.83k | 0.22% $ 9.7m | |
| Independent Director | 5.8yrs | US$394.40k | 0.042% $ 1.8m | |
| Independent Director | 15.8yrs | US$414.83k | 0.11% $ 5.0m | |
| Independent Director | 3.3yrs | US$409.80k | 0.035% $ 1.6m | |
| Independent Director | 2.8yrs | US$407.83k | 0.033% $ 1.5m |
10.0yrs
Durata media
66yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di SEM è composto da personale esperto e esperto (durata media dell'incarico 10 anni).